BRK-B vs FT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
FT exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a very conservative balance sheet (Debt/Equity 0.29). The stock is significantly undervalued, trading at $8.14, which is well below both its Graham Number ($12.11) and estimated Intrinsic Value ($22.71). While the technical trend is bearish and revenue has contracted by 27.1%, the combination of a low P/E (10.57), a P/B under 1.0, and a sustainable 6.27% dividend yield makes it a compelling value play.
Compare Another Pair
Related Comparisons
BRK-B vs FT: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Franklin Universal Trust (FT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.